Trust Co. of Toledo NA OH Boosts Position in Danaher Corporation (NYSE:DHR)

Trust Co. of Toledo NA OH increased its stake in Danaher Corporation (NYSE:DHR) by 1.8% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 37,641 shares of the conglomerate’s stock after buying an additional 673 shares during the period. Trust Co. of Toledo NA OH’s holdings in Danaher Corporation were worth $3,220,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Peddock Capital Advisors LLC boosted its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares in the last quarter. Motco boosted its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock valued at $158,000 after buying an additional 390 shares in the last quarter. Baystate Wealth Management LLC boosted its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock valued at $163,000 after buying an additional 60 shares in the last quarter. Integrated Investment Consultants LLC boosted its stake in Danaher Corporation by 22.1% in the first quarter. Integrated Investment Consultants LLC now owns 2,168 shares of the conglomerate’s stock valued at $185,000 after buying an additional 393 shares in the last quarter. Finally, Cedar Wealth Management LLC boosted its stake in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock valued at $196,000 after buying an additional 115 shares in the last quarter. 76.32% of the stock is currently owned by institutional investors and hedge funds.

Danaher Corporation (DHR) opened at 83.07 on Monday. The stock’s 50 day moving average is $84.47 and its 200-day moving average is $83.63. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01. The firm has a market capitalization of $57.66 billion, a PE ratio of 25.32 and a beta of 1.05.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, April 20th. The conglomerate reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.84 by $0.01. The firm had revenue of $4.21 billion during the quarter, compared to analysts’ expectations of $4.17 billion. Danaher Corporation had a return on equity of 11.82% and a net margin of 12.30%. The company’s revenue was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.08 earnings per share. Equities analysts expect that Danaher Corporation will post $3.92 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Shareholders of record on Friday, June 30th will be given a dividend of $0.14 per share. The ex-dividend date is Wednesday, June 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.67%. Danaher Corporation’s payout ratio is currently 17.02%.

TRADEMARK VIOLATION NOTICE: This article was originally reported by WKRB News and is the sole property of of WKRB News. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.wkrb13.com/markets/2284357/trust-co-of-toledo-na-oh-boosts-position-in-danaher-corporation-nysedhr.html.

DHR has been the topic of several research analyst reports. Credit Suisse Group reissued a “buy” rating and issued a $93.00 target price on shares of Danaher Corporation in a research report on Wednesday, May 24th. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $96.00 target price on the stock in a research report on Tuesday, April 4th. BTIG Research reissued a “buy” rating and issued a $92.00 target price on shares of Danaher Corporation in a research report on Sunday, April 23rd. Deutsche Bank AG reissued a “buy” rating and issued a $97.00 target price on shares of Danaher Corporation in a research report on Wednesday, June 21st. Finally, BidaskClub raised shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, June 21st. Two research analysts have rated the stock with a sell rating, two have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $92.26.

In other Danaher Corporation news, Director Donald J. Ehrlich acquired 600 shares of Danaher Corporation stock in a transaction dated Friday, April 21st. The stock was bought at an average cost of $82.76 per share, with a total value of $49,656.00. Following the completion of the transaction, the director now owns 84,800 shares of the company’s stock, valued at $7,018,048. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of the stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold 82,265 shares of company stock valued at $6,815,839 in the last ninety days. Company insiders own 12.20% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284357/trust-co-of-toledo-na-oh-boosts-position-in-danaher-corporation-nysedhr.html

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.